Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-19-024825)

Filing Details

Accession Number:: 0000899243-19-024825
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-10-02 21:36:48
Reporting Period:: 2019-09-30

Accepted Time:: 2019-10-02 21:36:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1415684	Musclepharm Corp	MSLP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1008190	Mark Blundell	C/O White Winston Select Asset Funds Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1559652	P Robert Mahoney	C/O White Winston Select Asset Funds Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1647702	M. Todd Enright	C/O White Winston Select Asset Funds Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1647837	Donald Feagan	C/O White Winston Select Asset Funds Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1647840	White Winston Select Asset Funds, Llc	265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1738154	White Winston Select Asset Fund Series Fund Mp-18, Llc	265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-30	626,826	$0.00	3,658,180	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On September 30, 2019, the Reporting Person purchased 626,826 shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock") in an off-market transaction.
For purposes of the transaction, the value of the Common Stock was deemed to be $0.45 per share, the last reported sale price of the Common Stock on the Transaction Date.